BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8316014)

  • 1. [DRG and the buy-sell system are imported crazes. Let us develop the Swedish administrative tradition!].
    Hemlin C; Lind MG
    Lakartidningen; 1993 Jun; 90(25):2357-60. PubMed ID: 8316014
    [No Abstract]   [Full Text] [Related]  

  • 2. [Profit interest will be the ideal of market-oriented health services. Monopoly can function in a democratic way].
    Bendz H
    Lakartidningen; 1993 Oct; 90(42):3628-9. PubMed ID: 8231505
    [No Abstract]   [Full Text] [Related]  

  • 3. [Buy and sell and emperor's new clothes].
    Arozenius S
    Lakartidningen; 1993 Mar; 90(11):1028-9. PubMed ID: 8464284
    [No Abstract]   [Full Text] [Related]  

  • 4. [Health care reforms].
    Nerdrum HJ
    Tidsskr Nor Laegeforen; 1993 Jun; 113(15):1887-9. PubMed ID: 8322338
    [No Abstract]   [Full Text] [Related]  

  • 5. A health plan that can work.
    Faltermayer E
    Fortune; 1993 Jun; 127(12):88-91, 94-6. PubMed ID: 10126139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [No to for-profit health care].
    Bertholds E
    Lakartidningen; 2007 Jul 11-24; 104(28-29):2094-5; discussion 2095. PubMed ID: 17702386
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost control and managed competition.
    Simmons HE; Goldberg MA
    Bus Health; 1993 Feb; 11(2):56, 55. PubMed ID: 10123812
    [No Abstract]   [Full Text] [Related]  

  • 8. Testimony on managed competition. The effects of cost control provisions on health expenditures.
    Reischauer RD
    Caring; 1993 Jun; 12(6):18, 20, 23-8. PubMed ID: 10125988
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness and cost-benefit analysis.
    New England Regional Genetics Group
    Genetic Resour; 1998; 11(2):20-1. PubMed ID: 12817579
    [No Abstract]   [Full Text] [Related]  

  • 10. Is GATS a concern for the Swedish healthcare system?
    Sebastián MS; Hurtig AK
    Scand J Public Health; 2007; 35(6):666-9. PubMed ID: 17853000
    [No Abstract]   [Full Text] [Related]  

  • 11. What will healthcare reform cost?
    White JH
    Health Prog; 1993 May; 74(4):15-7, 31. PubMed ID: 10125357
    [No Abstract]   [Full Text] [Related]  

  • 12. OK, Bill, it's time to pick your remedy.
    Kosterlitz J
    Natl J (Wash); 1993 Jan; 25(4):200-1. PubMed ID: 10124396
    [No Abstract]   [Full Text] [Related]  

  • 13. [Market-oriented steering systems were not effective in health care].
    Orn P
    Lakartidningen; 1995 Dec; 92(49):4646. PubMed ID: 8531513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Unforeseen shortages in market economy. Are there alternatives to the buy-sell system in health care?].
    Secher E
    Lakartidningen; 1993 Mar; 90(11):1020-1. PubMed ID: 8464281
    [No Abstract]   [Full Text] [Related]  

  • 15. Will managed competition work?
    Davis K
    Health PAC Bull; 1993; 23(1):25-6. PubMed ID: 10126173
    [No Abstract]   [Full Text] [Related]  

  • 16. Yes, the market can curb health costs.
    Faltermayer E
    Fortune; 1992 Dec; 126(14):84-8. PubMed ID: 10122927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paging Dr. Clinton.
    Castro J
    Time; 1993 Jan; 141(3):24-6. PubMed ID: 10123365
    [No Abstract]   [Full Text] [Related]  

  • 18. [DRG in Gothenburg. A secure system for cost surveys].
    Nilsson CA
    Lakartidningen; 1994 May; 91(18):1844-6. PubMed ID: 8189930
    [No Abstract]   [Full Text] [Related]  

  • 19. [Introduction of the DRG system in Germany: objectives, problems and perspectives on the basis of a lump sum payment from the perspective of the Federal Ministry of Health].
    Rau F
    Z Arztl Fortbild Qualitatssich; 2002 Aug; 96(8):498-504. PubMed ID: 12244869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care reform. Six questions for President Clinton.
    Wiener JM; Illston LH
    Brookings Rev; 1993; 11(2):22-5. PubMed ID: 10124884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.